China National Accord Medicines (SZSE:000028) Other Net Income (Loss)

: ¥-0 Mil (TTM As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

China National Accord Medicines's Other Net Income (Loss) for the three months ended in Dec. 2023 was ¥-0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 was ¥-0 Mil.

China National Accord Medicines's quarterly Other Net Income (Loss) increased from Jun. 2023 (¥0 Mil) to Sep. 2023 (¥0 Mil) but then declined from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥-0 Mil).

China National Accord Medicines's annual Other Net Income (Loss) declined from Dec. 2021 (¥0 Mil) to Dec. 2022 (¥-0 Mil) and declined from Dec. 2022 (¥-0 Mil) to Dec. 2023 (¥-0 Mil).

China National Accord Medicines Other Net Income (Loss) Historical Data

The historical data trend for China National Accord Medicines's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

China National Accord Medicines Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

China National Accord Medicines Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0 Mil.

China National Accord Medicines Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

China National Accord Medicines (SZSE:000028) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

200028:China

Address

No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029

Website

http://www.szaccord.com.cn

China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.

China National Accord Medicines (SZSE:000028) Headlines

No Headlines